PASSAGE BIO, INC. Basic Shares Outstanding (Weighted Average)
PASSAGE BIO, INC. (PASG) reported Basic Shares Outstanding (Weighted Average) of 3.21 million shares for the 3-month period ending 2026-06-30, per its S-4/A filed 2026-09-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-09-03
- PASSAGE BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 3.21M shares, a 1.26% increase year-over-year.
- PASSAGE BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 3.21M shares, a 1.33% increase year-over-year.
- PASSAGE BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 3.18M shares, a 0.90% increase year-over-year.
- PASSAGE BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 3.18M shares, a 1.02% increase year-over-year.
- PASSAGE BIO, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 54.74M shares, a 0.58% increase from fiscal 2022.
- PASSAGE BIO, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 54.43M shares, a 2.03% increase from fiscal 2021.
- PASSAGE BIO, INC. weighted average number of shares outstanding, basic for fiscal 2021 was 53.34M shares, a 38.14% increase from fiscal 2020.
- PASSAGE BIO, INC. weighted average number of shares outstanding, basic for fiscal 2020 was 38.62M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3.21M shares S-4/A · filed 2026-09-03 | 3.21M shares S-4/A · filed 2026-09-03 | 3.20M shares derived: average of 3 quarters · filed 2026-09-03 | 3.19M shares derived: average of 4 quarters · filed 2026-09-03 | ||||
| 2026-03-31 | 3.21M shares S-4 · filed 2026-07-21 | 3.19M shares derived: average of 2 quarters · filed 2026-09-03 | 3.19M shares derived: average of 3 quarters · filed 2026-09-03 | 3.18M shares derived: average of 4 quarters · filed 2026-09-03 | ||||
| 2025-12-31 | 3.18M shares derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-03 | 3.18M shares derived: average of 2 quarters · filed 2026-09-03 | 3.18M shares derived: average of 3 quarters · filed 2026-09-03 | 3.17M shares S-4/A · filed 2026-09-03 | ||||
| 2025-09-30 | 3.18M shares 10-Q · filed 2025-11-10 | 3.17M shares derived: average of 2 quarters · filed 2026-09-03 | 3.17M shares 10-Q · filed 2025-11-10 | 3.17M shares derived: average of 4 quarters · filed 2026-09-03 | ||||
| 2025-06-30 | 3.17M shares S-4/A · filed 2026-09-03 | 3.17M shares S-4/A · filed 2026-09-03 | 3.16M shares derived: average of 3 quarters · filed 2026-09-03 | 3.16M shares derived: average of 4 quarters · filed 2026-09-03 | ||||
| 2025-03-31 | 3.16M shares S-4 · filed 2026-07-21 | 62.11M shares 10-Q · filed 2025-05-13 | 3.16M shares derived: average of 2 quarters · filed 2026-09-03 | 3.15M shares derived: average of 3 quarters · filed 2026-09-03 | 3.15M shares derived: average of 4 quarters · filed 2026-09-03 | |||
| 2024-12-31 | 3.15M shares derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-03 | 3.15M shares derived: average of 2 quarters · filed 2026-09-03 | 3.15M shares derived: average of 3 quarters · filed 2026-09-03 | 3.08M shares S-4/A · filed 2026-09-03 | 60.41M shares 10-K · filed 2025-03-04 | |||
| 2024-09-30 | 3.15M shares 10-Q · filed 2025-11-10 | 61.76M shares 10-Q · filed 2024-11-13 | 3.14M shares derived: average of 2 quarters · filed 2025-11-10 | 3.05M shares 10-Q · filed 2025-11-10 | 59.92M shares 10-Q · filed 2024-11-13 | 29.37M shares derived: average of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | 3.14M shares 10-Q · filed 2025-08-12 | 61.68M shares 10-Q · filed 2024-08-08 | 3.01M shares 10-Q · filed 2025-08-12 | 58.99M shares 10-Q · filed 2024-08-08 | 38.11M shares derived: average of 3 quarters · filed 2025-08-12 | 42.28M shares derived: average of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | 56.30M shares 10-Q · filed 2025-05-13 | 55.59M shares derived: average of 2 quarters · filed 2025-05-13 | 55.32M shares derived: average of 3 quarters · filed 2025-05-13 | 55.16M shares derived: average of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | 54.88M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | 54.83M shares derived: average of 2 quarters · filed 2025-03-04 | 54.78M shares derived: average of 3 quarters · filed 2025-03-04 | 54.74M shares 10-K · filed 2025-03-04 | ||||
| 2023-09-30 | 54.79M shares 10-Q · filed 2024-11-13 | 54.74M shares derived: average of 2 quarters · filed 2024-11-13 | 54.70M shares 10-Q · filed 2024-11-13 | 54.67M shares derived: average of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | 54.68M shares 10-Q · filed 2024-08-08 | 54.65M shares 10-Q · filed 2024-08-08 | 54.63M shares derived: average of 3 quarters · filed 2024-08-08 | 54.59M shares derived: average of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | 54.62M shares 10-Q · filed 2024-05-14 | 54.60M shares derived: average of 2 quarters · filed 2024-05-14 | 54.56M shares derived: average of 3 quarters · filed 2024-05-14 | 54.51M shares derived: average of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | 54.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | 54.53M shares derived: average of 2 quarters · filed 2024-03-04 | 54.48M shares derived: average of 3 quarters · filed 2024-03-04 | 54.43M shares 10-K · filed 2024-03-04 | ||||
| 2022-09-30 | 54.47M shares 10-Q · filed 2023-11-13 | 54.43M shares derived: average of 2 quarters · filed 2023-11-13 | 54.38M shares 10-Q · filed 2023-11-13 | 54.32M shares derived: average of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | 54.39M shares 10-Q · filed 2023-08-07 | 54.33M shares 10-Q · filed 2023-08-07 | 54.27M shares derived: average of 3 quarters · filed 2023-08-07 | 54.20M shares derived: average of 4 quarters · filed 2023-08-07 | ||||
| 2022-03-31 | 54.28M shares 10-Q · filed 2023-05-11 | 54.20M shares derived: average of 2 quarters · filed 2023-05-11 | 54.14M shares derived: average of 3 quarters · filed 2023-05-11 | 54.07M shares derived: average of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | 54.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | 54.06M shares derived: average of 2 quarters · filed 2023-03-06 | 54.01M shares derived: average of 3 quarters · filed 2023-03-06 | 53.34M shares 10-K · filed 2023-03-06 | ||||
| 2021-09-30 | 54.00M shares 10-Q · filed 2022-11-10 | 53.94M shares derived: average of 2 quarters · filed 2022-11-10 | 53.08M shares 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | 53.89M shares 10-Q · filed 2022-08-04 | 52.62M shares 10-Q · filed 2022-08-04 | ||||||
| 2021-03-31 | 51.33M shares 10-Q · filed 2022-05-16 | |||||||
| 2020-12-31 | 38.62M shares 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |